AVITA Medical, Inc. (AVHHL)

Market Cap	253.60M +124.2%
Revenue (ttm)	75.63M +1.0%
Net Income	-43.08M
EPS	-1.44
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,575
Open	1.000
Previous Close	0.953
Day's Range	1.000 - 1.420
52-Week Range	0.555 - 1.420
Beta	1.85
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About AVITA Medical

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting devi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2020
• Employees: 226
• Stock Exchange: OTCMKTS
• Ticker Symbol: AVHHL

Financial Performance

In 2025, AVITA Medical's revenue was $71.61 million, an increase of 11.45% compared to the previous year's $64.25 million. Losses were -$48.59 million, -21.44% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 11, 2026

Data Sources Report a data error